SCHEMBL28683089

SCHEMBL28683089

CN1CCC(NC(=O)c2ccc(NC(=O)c3cccnc3)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.59
RAB9A P51151 5/20 0.59
MAPT P10636 5/20 0.59
NPC1 O15118 4/20 0.59
GAA P10253 1/20 0.59
TP53 P04637 3/20 0.55
ALDH1A1 P00352 3/20 0.55
GFER P55789 2/20 0.55
ROCK2 O75116 1/20 0.53
ROCK1 Q13464 1/20 0.53
NAMPT P43490 2/20 0.53
ATR Q13535 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
HTT P42858 1/20 0.52
LMNA P02545 1/20 0.51
HIF1A Q16665 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3955552 0.91 ALDH1A1 (0.62) SMN1; SMN2RAB9AMAPTALDH1A1L3MBTL1
SCHEMBL30365687 0.91 ALDH1A1 (0.62) SMN1; SMN2RAB9AMAPTALDH1A1L3MBTL1
SCHEMBL28702811 0.86 RAB9A (0.65) SMN1; SMN2RAB9AMAPTNPC1GAA
SCHEMBL10224770 0.84 ALDH1A1 (0.61) SMN1; SMN2RAB9AMAPTNPC1GAA
SCHEMBL357738 0.84 ALDH1A1 (0.61) SMN1; SMN2RAB9AMAPTNPC1GAA
SCHEMBL14082548 0.82 DYRK1A (0.63) SMN1; SMN2RAB9ANPC1ROCK2ATR
SCHEMBL7123963 0.82 RAB9A (0.57) SMN1; SMN2RAB9AMAPTNPC1GAA
SCHEMBL12879808 0.79 L3MBTL1 (0.61) NAMPTATRL3MBTL1MEN1KMT2A
SCHEMBL22236209 0.79 DYRK1A (0.52) SMN1; SMN2RAB9AMAPTNPC1GAA
SCHEMBL1116630 0.78 ALDH1A1 (0.78) SMN1; SMN2RAB9AMAPTGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108368083-B Heteroaryl compounds and their use as therapeutic agents 东亚首希控股股份有限公司 2022-02-01 CN disclosed